We observed that, while peptide C3f appears significantly increased only in serum from metastatic CRC patients, the increase of the prothrombin fragment is already evident in the serum of non-metastatic patients, suggesting its involvement in the early events of tumour progression. Here, F2 is linked to colorectal carcinoma.